Category:

Life

One in every two families paid over Rs 750 for COVID antibody test in India: Survey

According to the survey, 29 per cent of the respondents said they paid Rs 1,000 or more during their COVID antibody test. Further, 21 per cent said they paid between Rs 750-1000 and 14 per cent said they paid between Rs 500-750.

While, 24 per cent said they paid Rs 250-500 and 7 per cent said they paid less than Rs 250. 5 per cent respondents did not say anything. “On an aggregate basis, 50 per cent of citizens who got a COVID antibody test done paid over Rs 750 for it,” said LocalCircles release.

read more

Govt invites bids for second time from law firms for LIC IPO

The government is also mulling allowing foreign investors to pick up stakes in the country’s largest insurer. As per Sebi rules, foreign portfolio investors (FPIs) are permitted to buy shares in a public offer.However, since the LIC Act has no provision for foreign investments, there is a need to align the proposed LIC IPO with Sebi norms regarding foreign investor participation.

read more

Indian insurance sector: Shakeout or promoter exits to happen?

According to Exide Industries, it has invested a total of Rs 1,679.59 crore in Exide Life, a wholly-owned subsidiary and in turn, gets a value of Rs 6,687 crore on the sale.

Exide Life is the second life insurance company to be sold after AMP Sanmar Life Insurance was sold to Reliance Life Insurance, now Reliance Nippon Life Insurance.

The general insurance sector saw stake sale/purchase last year. Paytm acquired Raheja QBE, HDFC Ergo acquired Apollo Munich, Sachin Bansal bought DHFL General Insurance, and Bharti Axa General was acquired by ICICI Lombard.

read more

HDFC Life to acquire Exide Life for Rs 6,687 crore

The embedded value of Exide Life, as on 30th June 2021, is Rs. 2,711 crore will augment the existing embedded value of HDFC Life by approximately 10% Proposed transaction will accelerate the growth of Agency business of HDFC Life as well as strengthen other distribution channels including Broker, Direct and Co-operative Banks Complementary geographical presence with a strong foothold in South India, especially in Tier 2 and Tier 3 locations
Customers to benefit from stronger product suite, wider distribution network and more service touch points
▪ Synergies to enhance shareholder value with potential to improve new business margins via operating leverage and
product mix optimisation

read more

20 APAC re/insurers record a higher premium of $821.4bn in 2020, COVID induces demand for life & health products, GlobalData

Seven players reported more than 5% rise in premiums earned. In addition, the top companies maintained financial robustness through flexible hedging of assets under management.The most notable performers in the region were Japan-based insurer Dai-ichi Life, China-based New China Life Insurance and China Reinsurance; and Taiwan-based Cathay Financial.Dai-ichi Life outperformed the top players, with its revenue growth surpassing 20%, as the weaker Yen allowed the company’s returns from its investments soar significantly over the previous year.

China Reinsurance reported 19.2% increase in y-o-y revenue owing to swift growth in savings- and protection-type life, domestic P&C reinsurance, and health reinsurance business, which led to 16.2% growth in premium income; and obtaining surplus investment returns by surpassing the market benchmarks.

read more